We are live on
!
Find out more
TM
Tikvah Management Portfolio holdings
AUM
$323M
1-Year Est. Return
69.61%
This Fund
S&P 500
This Quarter
Est. Return
+2.6%
1 Year Est. Return
+69.61%
3 Year Est. Return
+173.03%
5 Year Est. Return
+103.33%
10 Year Est. Return
+586.01%
AUM
$135M
AUM Growth
–
Cap. Flow
+$133M
Cap. Flow
% of AUM
98.2%
Top 10 Holdings %
Top 10 Hldgs %
88.66%
Holding
17
New
17
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$35.3M |
| 2 |
Bio-Rad Laboratories Class A
BIO
|
+$12.2M |
| 3 |
NATI
National Instruments Corp
NATI
|
+$12.1M |
| 4 |
Berkshire Hathaway Class A
BRK.A
|
+$11.9M |
| 5 |
Bank of America
BAC
|
+$10.1M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 24.35% |
| 2 | Technology | 24.1% |
| 3 | Healthcare | 9.02% |
| 4 | Communication Services | 4.84% |
| 5 | Consumer Staples | 1.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
State Street SPDR S&P 500 ETF Trust
SPY
$790B
| $35.9M | 26.59% |
+192,214
| New | +$35.3M |
|
|
2
Berkshire Hathaway Class A
BRK.A
$1.1T
| $12.7M | 9.42% |
+68
| New | +$11.9M |
|
|
3
Bio-Rad Laboratories Class A
BIO
$8.71B
| $12.2M | 9.02% |
+95,197
| New | +$12.2M |
|
|
NATI
4
DELISTED
National Instruments Corp
NATI
| $11.6M | 8.6% |
+405,000
| New | +$12.1M |
|
|
5
Bank of America
BAC
$435B
| $10.3M | 7.65% |
+601,527
| New | +$10.1M |
|
6
Goldman Sachs
GS
$300B
| $9.11M | 6.74% |
+55,591
| New | +$9.35M |
|
7
Nice
NICE
$5.79B
| $8.36M | 6.19% |
+187,250
| New | +$7.57M |
|
|
QGENF
8
DELISTED
QIAGEN NV
QGENF
| $7.79M | 5.76% |
+369,425
| New | +$7.79M |
|
9
Alphabet (Google) Class C
GOOG
$4.36T
| $6.54M | 4.84% |
+235,600
| New | +$6.86M |
|
|
GUID
10
DELISTED
Guidance Software, Inc.
GUID
| $5.2M | 3.85% |
+470,259
| New | +$4.97M |
|
|
QADA
11
DELISTED
QAD Inc.
QADA
| $4.93M | 3.65% |
+241,270
| New | +$4.48M |
|
|
BRLI
12
DELISTED
BIO-REFERENCE LABS INC-NEW-
BRLI
| $3.18M | 2.35% |
+115,000
| New | +$3.01M |
|
|
CPLA
13
DELISTED
Capella Education Company
CPLA
| $2.49M | 1.84% |
+39,416
| New | +$2.56M |
|
|
ACCL
14
DELISTED
Accelrys Inc
ACCL
| $1.53M | 1.13% |
+122,935
| New | +$1.44M |
|
|
QADB
15
DELISTED
QAD Inc. Class B
QADB
| $1.31M | 0.97% |
+77,096
| New | +$1.28M |
|
16
ASML
ASML
$626B
| $1.16M | 0.86% |
+12,450
| New | +$1.11M |
|
17
LPL Financial
LPLA
$28.3B
| $726K | 0.54% |
+13,812
| New | +$729K |
|
Similar funds
GIM
CRI
BCP
UOC
BEP
AIA
FAL
AC
Tikvah Management's Q1 2014 Portfolio in Review
Q1 2014 is the first quarter with a 13F filing on record for Tikvah Management, which disclosed 17 positions worth $135M. Its ten largest holdings account for 89% of the portfolio.
Its largest position is State Street SPDR S&P 500 ETF Trust: 192,214 shares worth $35.9M.
By sector, the portfolio is most concentrated in Financials at 24% of assets, followed by Technology and Healthcare.
- Tikvah Management's largest Q1 2014 buy was State Street SPDR S&P 500 ETF Trust: 192,214 shares worth $35.9M.
- Tikvah Management's ten largest holdings make up 89% of its $135M portfolio in Q1 2014.
- Tikvah Management disclosed 17 positions in Q1 2014, its first 13F filing on record.
Based on Tikvah Management's 13F filing for Q1 2014, filed 15 May 2014.